An α-boron-substituted cyclosilopentenene compound, its preparation method and application

The preparation of α-boron-substituted cyclosilopentenene compounds via [4+1] cycloaddition reaction solves the problem of limited substrate range in the synthesis of silicon heterocyclic compounds in existing technologies, and realizes low-cost, high-efficiency compound synthesis and multifunctional transformation.

CN123106733APending Publication Date: 2026-11-17LANZHOU INSTITUTE OF CHEMICAL PHYSICS CHINESE ACADEMY OF SCIENCES
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202511412350.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-09-29
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing methods for synthesizing silicon heterocyclic compounds have limitations such as a limited range of reaction substrates, simple structures that are difficult to incorporate into complex structures, and high costs.

Method used

An α-boron-substituted cyclosilopentenene compound was prepared by a [4+1] cycloaddition reaction using compound 1, compound 2, a reducing agent, and an organic solvent in the presence of a catalyst. The molar ratio of compound 1 to compound 2 was 1:1 to 3, the molar ratio of catalyst to compound 1 was 10 to 20:100, the reaction temperature was 40 to 80 °C, and the reaction time was 20 to 24 h.

Benefits of technology

The synthesis of compounds with simple operation and low cost has been achieved. The α-boron-substituted cyclosilopentenene compounds prepared have abundant functional groups, are suitable for multifunctional transformation, and expand their application range.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106733A_ABST
    Figure CN123106733A_ABST
Patent Text Reader

Abstract

This invention belongs to the field of organic compound technology, specifically relating to an α-boron-substituted cyclosilopentenene compound, its preparation method, and its application. The preparation method of the α-boron-substituted cyclosilopentenene compound provided by this invention includes the following steps: mixing compound 1, compound 2, a reducing agent, and an organic solvent, and then performing a [4+1] cycloaddition reaction to obtain the α-boron-substituted cyclosilopentenene compound; the structural formula of compound 1 is [insert structural formula here], and the structural formula of compound 2 is [insert structural formula here]. Wherein, R1 is a first aryl group, an aromatic heterocycle, or a first alkyl group; R2 is hydrogen or methyl; R3 is a second aryl group or a second alkyl group; and R4 is a third aryl group or a third alkyl group. When R1 is a first alkyl group or compound 1 is [insert structural formula here], the system undergoing the cycloaddition reaction contains a catalyst. The preparation method provided by this invention is simple to operate, uses widely available and low-cost raw materials, and is applicable to various aryl and alkyl conjugated diene borate esters, with broad applicability of functional groups.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of organic compound technology, specifically relating to an α-boron-substituted cyclosilopentenene compound, its preparation method, and its application. Background Technology

[0002] Silicon heterocyclic compounds, due to their unique cyclic structure and the introduction of silicon, exhibit significantly different biological activities from carbon-based compounds, possessing advantages such as lower toxicity and higher lipophilicity, leading to their wide application in organic synthesis, medicinal chemistry, and materials science. Currently, most synthetic methods for silicon heterocyclic compounds employ metal catalysis, utilizing intramolecular or intermolecular cyclization reactions of pre-introduced silicon groups (such as Si-H or Si-Me bonds) or ring-expansion reactions of ring-strained silicon-carbon rings, resulting in a limited substrate range. Therefore, developing novel, efficient, economical, practical synthetic methods with a broad range of substrate sources is of great significance.

[0003] Furthermore, although numerous methods for synthesizing silicon heterocyclic compounds have been reported, the synthesized compounds are mostly relatively simple in structure. It is difficult to introduce silicon heterocyclic compounds as fragments into complex structures, and the synthetic transformation lacks linkage. Summary of the Invention

[0004] In view of this, the present invention provides an α-boron-substituted cyclosilopentenene compound, its preparation method and application. The preparation method provided by the present invention is simple to operate and low in cost, and the prepared compound contains a rich variety of functional groups and can undergo multifunctional transformation.

[0005] To address the aforementioned technical problems, this invention provides a method for preparing α-boron-substituted cyclosilopentenene compounds, comprising the following steps:

[0006] Compound 1, compound 2, reducing agent and organic solvent were mixed and subjected to a [4+1] cycloaddition reaction to obtain α-boron-substituted cyclosilopentenene compounds;

[0007] The structural formula of compound 1 is as follows: The structural formula of compound 2 is as follows:

[0008] Wherein, R1 is a first aryl, aromatic heterocyclic or first alkyl; R2 is hydrogen or methyl; R3 is a second aryl or second alkyl; and R4 is a third aryl or third alkyl.

[0009] When R1 is the first alkyl group or compound 1 is In this case, the system undergoing the cycloaddition reaction contains a catalyst.

[0010] Preferably, the first aryl group includes 2-naphthyl, phenyl, or a first substituted phenyl group, the aromatic heterocycle includes benzodioxane, benzo4-membered ring, benzo5-membered ring, or furanyl, and the first alkyl group includes cyclohexyl, propyl, or n-octyl.

[0011] The second aryl group includes phenyl or a second substituted phenyl group, and the second alkyl group includes methyl, n-propyl, isopropyl, or n-butyl.

[0012] The third aryl group includes phenyl or a third substituted phenyl group, and the third alkyl group includes methyl, n-propyl, isopropyl, or n-butyl.

[0013] Preferably, the substituents in the first substituted phenyl group include methyl, m-methyl, 3,4-dimethyl, ethyl, methoxy, ethoxy, o-methoxy, 3,4-dimethoxy, 3,4,5-trimethoxy, tert-butyl, phenyl, methylthio, N,N-dimethyl, benzylmethoxy, propoxy, fluorine, trimethylsilylalkynyl, etc.

[0014] The substituents in the second substituted phenyl group include methyl, tert-butyl, n-butyl, or methoxy.

[0015] The substituents in the third substituted phenyl group include methyl, tert-butyl, n-butyl, or methoxy.

[0016] Preferably, the molar ratio of compound 1 to compound 2 is 1:1 to 3;

[0017] The reducing agent includes magnesium powder, and the molar ratio of the reducing agent to compound 1 is 1 to 3:1;

[0018] The organic solvent includes ethylene glycol dimethyl ether;

[0019] The catalyst includes trichlorotitanium, and the molar ratio of the catalyst to compound 1 is 10-20:100.

[0020] Preferably, the [4+1] cycloaddition reaction is carried out at a temperature of 40–80°C for 20–24 hours.

[0021] Preferably, the [4+1] cycloaddition reaction is carried out under a protective atmosphere, which includes nitrogen or argon.

[0022] Preferably, the [4+1] cycloaddition reaction further includes: separating and concentrating the system after the [4+1] cycloaddition reaction by column chromatography to obtain the α-boron-substituted cyclosilopentenene compound;

[0023] The eluent used for column chromatography separation is a mixed solution of petroleum ether and ethyl acetate, wherein the volume ratio of petroleum ether to ethyl acetate is 20 to 100:1.

[0024] This invention also provides α-boron-substituted cyclosilopentenene compounds prepared by the preparation method described above, having any one of the structural formulas shown in Formulas 1 to 4:

[0025]

[0026] Wherein, R1 is a first aryl, aromatic heterocyclic or first alkyl; R2 is hydrogen or methyl; R3 is a second aryl or second alkyl; and R4 is a third aryl or third alkyl.

[0027] Preferably, it has any of the following structures:

[0028]

[0029]

[0030] This invention also provides the application of the α-boron-substituted cyclosilopentenene compounds described above in the fields of organic synthesis, medicinal chemistry, or materials science.

[0031] This invention provides a method for preparing α-boron-substituted cyclosilopentenene compounds, comprising the following steps: mixing compound 1, compound 2, a reducing agent, and an organic solvent, and then performing a [4+1] cycloaddition reaction to obtain α-boron-substituted cyclosilopentenene compounds; the structural formula of compound 1 is as follows: The structural formula of compound 2 is as follows: Wherein, R1 is a first aryl, aromatic heterocyclic, or first alkyl; R2 is hydrogen or methyl; R3 is a second aryl or second alkyl; and R4 is a third aryl or third alkyl. When R1 is a first alkyl or compound 1 is... The system undergoing the cycloaddition reaction contains a catalyst. The preparation method provided by this invention is simple to operate, uses widely available and low-cost raw materials, and is applicable to a wide variety of aryl and alkyl conjugated dienyl borate esters, with broad applicability of functional groups.

[0032] The α-boron-substituted cyclosilopentenene compounds prepared according to the preparation method provided by this invention have abundant functional groups and can undergo multifunctional transformations, thus expanding their application range. Detailed Implementation

[0033] This invention provides a method for preparing α-boron-substituted cyclosilopentenene compounds, comprising the following steps:

[0034] Compound 1, compound 2, reducing agent and organic solvent were mixed and subjected to a [4+1] cycloaddition reaction to obtain α-boron-substituted cyclosilopentenene compounds;

[0035] The structural formula of compound 1 is as follows: The structural formula of compound 2 is as follows:

[0036] Wherein, R1 is a first aryl, aromatic heterocyclic or first alkyl; R2 is hydrogen or methyl; R3 is a second aryl or second alkyl; and R4 is a third aryl or third alkyl.

[0037] In this invention, when R1 is a first alkyl group or compound 1 is... In this invention, the system undergoing the cycloaddition reaction contains a catalyst, which may include titanium trichlorocerocene. The molar ratio of the catalyst to compound 1 can be 10–20:100, specifically 10:100, 15:100, or 20:100. The catalyst used in this invention is a titanium catalyst, which is abundant and inexpensive on Earth, significantly reducing production costs.

[0038] In this invention, R1 is a first aryl group, an aromatic heterocyclic ring, or a first alkyl group; the first aryl group includes 2-naphthyl, phenyl, or a first substituted phenyl group, and the substituents in the first substituted phenyl group may include methyl, m-methyl, 3,4-dimethyl, ethyl, methoxy, ethoxy-o-methoxy, 3,4-dimethoxy, 3,4,5-trimethoxy, tert-butyl, phenyl, methylthio, N,N-dimethyl, benzylmethoxy, propoxy, fluorine, trimethylsilylalkynyl, etc.

[0039] In one specific embodiment of the present invention, the aromatic heterocycle may include benzodioxane, benzo4-membered ring, benzo5-membered ring or furanyl, and the first alkyl group may include cyclohexyl, propyl or n-octyl.

[0040] In this invention, R3 is a second aryl group or a second alkyl group, the second aryl group may include a phenyl group or a second substituted phenyl group, and the substituents in the second substituted phenyl group include methyl, tert-butyl, n-butyl, or methoxy groups; the second alkyl group may include methyl, n-propyl ( n Pr), isopropyl ( i Pr) or n-butyl.

[0041] In this invention, R4 is a third aryl or a third alkyl group, wherein the third aryl group may include a phenyl or a third-substituted phenyl group, and the substituents in the third-substituted phenyl group may include methyl, tert-butyl, n-butyl, or methoxy groups; the third alkyl group may include methyl, n-propyl ( n Pr), isopropyl ( i Pr) or n-butyl.

[0042] In this invention, R3 and R4 can be the same.

[0043] In this invention, when R1 is a first aryl or aromatic heterocyclic compound, compound 1 can be 4,4,5,5-tetramethyl-2-((1E,3E)-4-phenylbutyl-1,3-dien-1-yl)-1,3,2-dioxaborane, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxaborane, 2-((1E,3E)-4-(4-methoxyphenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(4-(methylthio)phenyl)but-1,3- Dien-1-yl)-1,3,2-dioxoborane, 2-((1E,3E)-4-([1,1'-biphenyl]-4-yl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxoborane, N,N-dimethyl-4-((1E,3E)-4-(4,4,5,5-tetramethyl-1,3,2-dioxobor-2-yl)but-1,3-dien-1-yl)aniline, 2-((1E,3E)-4-(2-methoxyphenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(m-tolyl)but-1,3 -dien-1-yl)-1,3,2-dioxoborane, trimethyl((4-((1E,3E)-4-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)but-1,3-dien-1-yl)phenyl)ethynyl)silane, 1-(4-((1E,3E)-4-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)but-1,3-dien-1-yl)phenyl)-1H-pyrrole, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(4-(thiophene-2-yl)phenyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane, 2-((1E,3E)-4-(7-methoxybenzo) [d][1,3]dioxo-5-yl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane, 2-((1E,3E)-4-(4-(benzyloxy)phenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane, 4,4,5,5-tetramethyl-2-((1E,3E)-3-methyl-4-phenylbut-1,3-dien-1-yl)-1,3,2-dioxaborane, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(3,4,5-trimethoxyphenyl)but-1,3-dien-1-yl)-1,3,2-dioxaborane, 4,4,5,5-Tetramethyl-2-((1E,3E)-4-(naphth-2-yl)but-1,3-dien-1-yl)-1,3,2-dioxoborane, 2-((1E,3E)-4-(4-(tert-butyl)phenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxoborane, 2-((1E,3E)-4-(4-ethylphenyl)but-1,3-dien-1-yl)-4,4,5, 5-Tetramethyl-1,3,2-dioxaborane, 2-((1E,3E)-4-(4-fluorophenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(4-propoxyphenyl)but-1,3-dien-1-yl)-1,3,2-dioxaborane, 2-((1E,3E)-4-(3,4-dioxaborane)-2- ... 2-((1E,3E)-4-(3,4-dimethylphenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane, 2-((1E,3E)-4-(3,4-dimethylphenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane, 2-((1E,3E)-4-(bicyclo[4.2.0]octane-1(6),2,4-trien-3-yl)but-1,3-dioxaborane 2-((1E,3E)-4-(2,3-dihydro-1H-inden-5-yl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxoborane, 2-((1E,3E)-4-(furan-2-yl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxoborane,

[0044] In this invention, when R1 is a first alkyl group, compound 1 can be 4,4,5,5-tetramethyl-2-((1E,3E)-6-phenylhexa-1,3-dien-1-yl)-1,3,2-dioxaborane, 2-((1E,3E)-hept-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane, or 2-((1E,3E)-4-cyclohexylbutyl-1,3-dien-1-yl)-4,4,5,5- Tetramethyl-1,3,2-dioxaborane, 2-((1E,3E)-dodecane-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane, (E)-2-(2-(cyclopent-1-en-1-yl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane or (E)-2-(2-(cyclohex-1-en-1-yl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane.

[0045] In this invention, the dichlorosilane can be 1,1-dichlorosilylcyclobutane, 1,1-dichloro-silanecyclopentane, 1,1-dichloro-silanecyclohexane, bis(4-(tert-butyl)phenyl)dichlorosilane, dichlorodi-p-tolylsilane, dibutylsilane, dipropylsilane, diisopropyldichlorosilane, dimethylsilane, or dichlorobis(3-methoxyphenyl)silane.

[0046] In one specific embodiment of the present invention, the molar ratio of compound 1 and compound 2 can be 1:1 to 3, specifically 1:1, 1:2 or 1:3.

[0047] In one specific embodiment of the present invention, the reducing agent may include magnesium powder, and the molar ratio of the reducing agent to compound 1 may be 1 to 3:1, specifically 1:1, 1:2 or 1:3.

[0048] In one specific embodiment of the present invention, the organic solvent may include ethylene glycol dimethyl ether. The present invention does not impose a particular limitation on the amount of the organic solvent used, as long as it is sufficient to fully dissolve the reactants.

[0049] In one specific embodiment of the present invention, the mixing can be carried out in a pressure-resistant tube, which can withstand high temperature and high pressure while maintaining a good closed state containing protective gas.

[0050] In one specific embodiment of the present invention, the temperature of the [4+1] cycloaddition reaction can be 40–80°C, specifically 40°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C, 75°C, or 80°C; the time of the [4+1] cycloaddition reaction can be 20–24 hours, specifically 20 hours, 21 hours, 22 hours, 23 hours, or 24 hours. In another specific embodiment of the present invention, the [4+1] cycloaddition reaction can be accompanied by stirring. The present invention does not have any special limitations on the stirring, as long as the reaction can proceed fully.

[0051] In one specific embodiment of the present invention, the [4+1] cycloaddition reaction can be carried out under a protective atmosphere, which includes nitrogen or argon; the pressure of the protective atmosphere can be 0.8 to 1.2 atm, specifically 1 atm.

[0052] In this invention, when R1 is a first aryl group or an aromatic heterocycle, compound 2 is... The [4+1] cycloaddition reaction is carried out as shown in formula a, where R1 is the first alkyl group and compound 2 is... The [4+1] cycloaddition reaction is carried out as shown in formula b. When R1 is a first aryl group, an aromatic heterocyclic ring, or a first alkyl group, compound 2 is... The [4+1] cycloaddition reaction is carried out as shown in formula c, when compound 1 is... Compound 2 is The [4+1] cycloaddition reaction is carried out as shown in equation d, when R1 is... Compound 2 is The [4+1] cycloaddition reaction is carried out in the manner shown in equation e:

[0053]

[0054]

[0055] In one specific embodiment of the present invention, the [4+1] cycloaddition reaction may further include: concentrating the system after the [4+1] cycloaddition reaction by column chromatography to obtain the α-boron-substituted cyclosilopentenene compound; the eluent for the column chromatography is a mixed solution of petroleum ether and ethyl acetate, and the volume ratio of petroleum ether to ethyl acetate can be 20–100:1, specifically 20:1, 30:1, 40:1, 50:1, 60:1, 70:1, 80:1, 90:1, or 100:1; the concentration includes rotary evaporation under reduced pressure. The present invention does not have any particular limitation on the rotary evaporation under reduced pressure, and conventional methods in the art can be used.

[0056] The preparation method provided by this invention is simple to operate and low in cost. It can not only achieve the cyclosilicification reaction of aryl conjugated dienyl borate esters under mild conditions, but also achieve the cyclization of alkyl conjugated dienyl borate esters by adding a catalytic amount of abundant titanium, thereby preparing silane heterocyclic compounds, including some α-boron-substituted spirocyclic silane heterocyclic compounds. The α-boron-substituted cyclosilopentenene compounds prepared according to the method provided by this invention can undergo a variety of subsequent transformations, and also provide the possibility of introducing silane heterocyclic compounds into complex molecules.

[0057] This invention also provides α-boron-substituted cyclosilopentenene compounds prepared by the preparation method described above, having any one of the structural formulas shown in Formulas 1 to 4:

[0058]

[0059] Wherein, R1 is a first aryl, aromatic heterocyclic or first alkyl; R2 is hydrogen or methyl; R3 is a second aryl or second alkyl; and R4 is a third aryl or third alkyl.

[0060] In one specific embodiment of the present invention, when R2 is hydrogen, R1 can be...

[0061] In one specific embodiment of the present invention, R3 and R4 are the same, and both R3 and R4 can be... methyl, n-propyl ( n Pr), isopropyl ( i Pr) or n-butyl ( n Bu)

[0062] As a specific embodiment of the present invention, the α-boron-substituted cyclosilopentenene compound has any of the following structures:

[0063]

[0064] This invention also provides applications of the α-boron-substituted cyclosilopentenene compounds described above in organic synthesis, medicinal chemistry, or materials science. This invention adds easily convertible boronate groups to the silicon heterocycle, utilizing the abundant convertibility of borate groups to introduce the silicon heterocycle skeleton into bioactive molecules and drug molecules. This invention provides a method for preparing α-boron-substituted cyclosilopentenene compounds through a metal-free [4+1] cycloaddition reaction between aryl conjugated dienyl boronate compounds and inexpensive, readily available, and abundant dichlorosilanes. The substrate is extended to alkyl conjugated dienyl boronate esters (requiring the addition of a small amount of titanium as a catalyst), thereby preparing a series of α-boron-substituted cyclosilopentenene compounds and silicospirocyclopentene compounds.

[0065] To further illustrate the present invention, the technical solutions provided by the present invention will be described in detail below with reference to the embodiments, but they should not be construed as limiting the scope of protection of the present invention.

[0066] Example 1

[0067] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-phenylbutyl-1,3-dien-1-yl)-1,3,2-dioxaborane (denoted as 1a, 0.2 mmol, 51.2 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was then placed in the solution. The mixture was stirred in a 15 mL pressure-resistant tube at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in 3a (colorless oil, 1,1,2-triphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 68%. The chemical reaction formula for the above preparation process is as follows:

[0068]

[0069] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.70-7.64(m,2H),7.37-7.33(m,3H),7.11-7.01(m,8H),7.00-6.95(m,2H),6.24(dt,J=7. 1,2.5Hz,1H),6.05(dt,J=7.1,2.7Hz,1H),3.67(q,J=2.5Hz,1H),1.96(q,J=2.5Hz,1H),0.94(d,J=33.7Hz,12H). 13 C NMR (101MHz, CDCl3) δ142.57,136.12,134.95,134.68,132.75,129.67,129.34,1 28.04,127.70,126.99,124.50,83.16,77.36,77.04,76.73,39.96,24.95,24.73. 11 BNMR(128MHz,CDCl3)δ34.52.HRMS(ESI)m / z:[M+H] + calcd for C 28 H 32 BO2Si + :439.2259; found:439.2258.

[0070] Example 2

[0071] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was then placed in the 15 mL of the glove box. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in 3b (yellow oil, 1,1-diphenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-5-(p-tolyl)-2,5-dihydro-1H-silicon), with a separation yield of 51%. The chemical reaction formula for the above preparation process is as follows:

[0072]

[0073] The characterization data are: 1H NMR (400MHz, CDCl3) δ7.69-7.63(m,2H),7.35-7.32(m,2H),7.13-7.06(m,4H),6.98(dt,J=7.6,3.5Hz,4H),6.86(d,J=7.8Hz,2H),6.21 (dt,J=7.1,2.6Hz,1H),6.03(dt,J=7.0,2.7Hz,1H),3.62(q,J=2.6Hz,1H),2.15(s,3H),1.95(q,J=2.5Hz,1H),0.93(d,J=33.4Hz,12H). 13 C NMR (101MHz, CDCl3) δ139.33,137.21,136.18,136.08,135.17,134.97,134.55,134.39,133.81,132.53,132. 38,129.63,129.33,128.78,128.03,127.64,127.01,83.14,77.38,77.06,76.75,39.54,24.96,24.73,20.95. 11 BNMR(128MHz,CDCl3)δ34.37.HRMS(ESI)m / z:[M+Na] + calcd for C 29 H 33 BO2SiNa + :475.2235; found:475.2240.

[0074] Example 3

[0075] In a nitrogen-filled glove box, 2-((1E,3E)-4-(4-methoxyphenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1c, 0.2 mmol, 54.4 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15-cell atmosphere with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in 3c (colorless oil, 2-(4-methoxyphenyl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 49%. The chemical reaction formula for the above preparation process is as follows:

[0076]

[0077] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.74-7.69(m,2H),7.44-7.38(m,3H),7.21-7.13(m,3H),7.11-7.03(m,4H),6.72-6.66(m,2H),6.28(dt,J= 7.1,2.6Hz,1H),6.09(dt,J=7.1,2.7Hz,1H),3.73(s,3H),3.67(q,J=2.6Hz,1H),2.02(q,J=2.5Hz,1H),1.01(d,J=31.2Hz,12H). 13 C NMR (101MHz, CDCl3) δ156.93,136.16,136.12,135.12,134.90,134.58,132.49,132.36,129.61,1 29.33,128.56,128.02,127.05,113.59,83.14,77.36,77.04,76.73,55.29,38.90,24.94,24.74. 11 B NMR(128MHz,CDCl3)δ34.00.HRMS(ESI)m / z:[M+Na] + calcdfor C 29 H 33 BO3SiNa + :491.2184; found:491.2191.

[0078] Example 4

[0079] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(4-(methylthio)phenyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1d, 0.2 mmol, 60.4 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 80°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in 3d (colorless oil, 2-(4-(methylthio)phenyl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 53%. The chemical reaction formula for the above preparation process is as follows:

[0080]

[0081] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.77-7.68(m,2H),7.47-7.39(m,3H),7.22-7.04(m,9H),6.31(dt,J=7.1,2.6Hz,1H),6. 08(dt,J=7.1,2.7Hz,1H),3.69(q,J=2.5Hz,1H),2.40(s,3H),2.03(q,J=2.5Hz,1H),1.01(d,J=33.6Hz,12H). 13 C NMR (101MHz, CDCl3) δ140.18,136.09,135.77,134.91,134.62,133.44,132.85,132.19,129.71,129. 45,128.26,128.06,127.51,127.10,83.19,77.36,77.25,77.04,76.72,39.55,24.96,24.72,16.89. 11 B NMR(128MHz,CDCl3)δ34.02.HRMS(ESI)m / z:[M+Na] + calcd for C 29 H 33 BO2SSiNa + :507.1956; found:507.1956.

[0082] Example 5

[0083] In a nitrogen-filled glove box, 2-((1E,3E)-4-([1,1'-biphenyl]-4-yl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxoborane (denoted as 1e, 0.2 mmol, 66.4 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with structure 3e (colorless oil, 2-([1,1'-biphenyl]-4-yl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 43%. The chemical reaction formula for the above preparation process is as follows:

[0084]

[0085] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.78-7.73(m,2H),7.55-7.51(m,2H),7.49-7.32(m,8H),7.31-7.26(m,1H),7.23(s,1H),7.19-7.14(m,3H),7.07-7. 02(m,2H),6.34(dt,J=7.1,2.5Hz,1H),6.15(dt,J=7.0,2.7Hz,1H),3.78(q,J=2.5Hz,1H),2.06(q,J=2.5Hz,1H),1.02(d,J=33.5Hz,12H). 13 CNMR(101MHz, CDCl3)δ141.93,141.30,137.32,136.15,135.87,134.96,134.62,132.90,132.25,129.72,1 29.43,128.66,128.11,128.08,127.06,126.85,126.75,83.20,77.37,77.05,76.73,39.75,24.97,24.75. 11 BNMR(128MHz,CDCl3)δ33.89.HRMS(ESI)m / z:[M+Na] + calcd for C 34 H 35 BO2SiNa +:537.2392; found:537.2400.

[0086] Example 6

[0087] In a nitrogen-filled glove box, N,N-dimethyl-4-((1E,3E)-4-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)but-1,3-dien-1-yl)aniline (denoted as 1f, 0.2 mmol, 59.8 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A 15 mL container with a magnetic magnet was then placed in the container. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (40:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in 3f (colorless oil, 4-(1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-siloxy-2-yl)-N,N-dimethylaniline), with a separation yield of 47%. The chemical reaction formula for the above preparation process is as follows:

[0088]

[0089] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.79-7.68(m,2H),7.48-7.35(m,3H),7.22-7.14(m,3H),7.10-6.99(m,4H),6.63-6.55(m,2H),6.26(dt,J= 7.0,2.6Hz,1H),6.10(dt,J=7.0,2.7Hz,1H),3.64(q,J=2.6Hz,1H),2.84(s,6H),2.01(q,J=2.5Hz,1H),1.00(d,J=31.3Hz,12H). 13 C NMR (101MHz, CDCl3) δ148.40,136.36,136.25,135.65,134.97,132.79,131.83,129.52,129. 24,128.35,127.98,127.03,113.42,83.08,77.38,77.06,76.74,41.23,38.79,24.94,24.73. 11 B NMR(128MHz,CDCl3)δ33.20.HRMS(ESI)m / z:[M+H] + calcdfor C 30 H37 BNO2Si + 482.2681; found: 482.2704.

[0090] Example 7

[0091] In a nitrogen-filled glove box, 2-((1E,3E)-4-(2-methoxyphenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1 g, 0.2 mmol, 57.2 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic field was then placed in the glove box. The mixture was stirred in a pressure-resistant tube at 80°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain 3 g of the compound with the indicated structure (colorless oil, 2-(2-methoxyphenyl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 46%. The chemical reaction formula for the above preparation process is as follows:

[0092]

[0093] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.97-7.76(m,2H),7.46-7.29(m,3H),7.20(dd,J=7.5,1.7Hz, 1H),7.00(tt,J=6.4,2.3Hz,1H),6.96-6.80(m,5H),6.76(td,J=7.5,1.2Hz,1H),6. 42(dd,J=8.1,1.2Hz,1H),6.21(dt,J=7.1,2.5Hz,1H),6.09(dt,J=7.1,2.7Hz,1H), 3.83(q,J=2.3Hz,1H),3.32(s,3H),1.87(q,J=2.4Hz,1H),0.88(d,J=70.4Hz,12H). 13C NMR (101MHz, CDCl3) δ155.84,136.17,135.55,135.32,133.53,133.32,132.89,131.45,129.36,128.83,1 27.83,126.96,126.52,125.32,120.16,109.15,82.95,77.38,77.06,76.74,54.42,32.24,25.15,24.54. 11 B NMR(128MHz,CDCl3)δ34.91.HRMS(ESI)m / z:[M+Na] + calcd for C 29 H 33 BO3SiNa + :491.2184; found:491.2194.

[0094] Example 8

[0095] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(m-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1h, 0.2 mmol, 54.0 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was then placed in the 15 mL of the glove box. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in the figure (colorless oil, 1,1-diphenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-5-(m-tolyl)-2,5-dihydro-1H-silicone oil), with a separation yield of 41%. The chemical reaction formula for the above preparation process is as follows:

[0096]

[0097] The characterization data are: 1H NMR (400MHz, CDCl3) δ7.70-7.62(m,2H),7.38-7.30(m,3H),7.12-7.03(m,3H),7.00-6.87(m,5H),6.74(dt,J=7.2,1.8Hz,1H),6.23(d t,J=7.1,2.6Hz,1H),6.03(dt,J=7.1,2.7Hz,1H),3.62(q,J=2.5Hz,1H),2.12(s,3H),1.95(q,J=2.5Hz,1H),0.93(d,J=31.5Hz,12H). 13 C NMR (101MHz, CDCl3) δ142.41,137.49,136.17,136.07,134.95,134.88,132.58,132.49,129.64,129.34,1 28.53,128.04,127.90,126.96,125.26,124.89,83.15,77.38,77.07,76.75,39.88,24.99,24.71,21.39. 11 B NMR(128MHz,CDCl3)δ32.73.HRMS(ESI)m / z:[M+Na] + calcd for C 29 H 33 BO2SiNa + :475.2235; found:475.2242.

[0098] Example 9

[0099] In a nitrogen-filled glove box, trimethyl((4-((1E,3E)-4-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)but-1,3-dien-1-yl)phenyl)ethynyl)silane (denoted as 1i, 0.2 mmol, 70.4 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A 15 mL container with a magnetic magnet was then placed in the container. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in 3i (colorless oil, 1,1-diphenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-5-(4-((trimethylsilyl)ethynyl)phenyl)-2,5-dihydro-1H-siloxane), with a separation yield of 41%. The chemical reaction formula for the above preparation process is as follows:

[0100]

[0101] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.81-7.66(m,2H),7.48-7.41(m,3H),7.30-7.23(m,3H),7.18-7.07(m,6H),6.35(dt,J=7.1,2.6H z,1H),6.10(dt,J=7.0,2.7Hz,1H),3.74(q,J=2.5Hz,1H),2.06(q,J=2.5Hz,1H),1.03(d,J=34.1Hz,12H),0.25(s,9H). 13 CNMR(101MHz, CDCl3)δ143.72,135.95,134.77,134.14,133.14,131.70,129.68,129.46,128.00,127.4 7,127.08,118.80,105.74,92.74,83.14,77.28,77.16,76.96,76.64,40.21,24.86,24.65,0.00,-0.06. 11 B NMR(128MHz,CDCl3)δ33.12.HRMS(ESI)m / z:[M+Na] + calcdfor C 33 H 39 BO2Si2Na + :557.2474; found:557.2493.

[0102] Example 10

[0103] In a nitrogen-filled glove box, 1-(4-((1E,3E)-4-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)but-1,3-dien-1-yl)phenyl)-1H-pyrrole (denoted as 1j, 0.2 mmol, 64.2 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound shown in Figure 3j (yellow oil, 1-(4-(1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-siloxy-2-yl)phenyl)-1H-pyrrole), with a separation yield of 69%. The chemical reaction formula for the above preparation process is as follows:

[0104]

[0105] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.82-7.67(m,2H),7.48-7.40(m,3H),7.22-7.11(m,7H),7.05(t,J=7.5Hz,2H),7.00(t,J=2.2Hz,2 H),6.41-6.21(m,3H),6.11(dt,J=7.1,2.7Hz,1H),3.75(q,J=2.5Hz,1H),2.04(q,J=2.5Hz,1H),1.02(d,J=33.4Hz,12H). 13 C NMR (101MHz, CDCl3) δ140.35,137.67,136.08,135.68,134.92,134.39,133.13,132.12,129.79,129.52,1 28.57,128.12,127.80,127.13,120.31,119.35,109.87,83.24,77.37,77.06,76.74,39.38,25.00,24.76. 11 B NMR(128MHz,CDCl3)δ34.65.HRMS(ESI)m / z:[M+Na] + calcd for C 32 H 34 BNO2SiNa + :526.2344; found:526.2352.

[0106] Example 11

[0107] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(4-(thiophen-2-yl)phenyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1k, 0.2 mmol, 64.2 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3k (yellow oil, 1,1-diphenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaboron-2-yl)-5-(4-(thiophene-2-yl)phenyl)-2,5-dihydro-1H-silicon), with a separation yield of 57%. The chemical reaction formula for the above preparation process is as follows:

[0108]

[0109] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.80-7.70(m,2H),7.45-7.35(m,5H),7.23-7.12(m,7H),7.09-7.00(m,3H),6.33(dt,J=7. 1,2.6Hz,1H),6.12(dt,J=7.0,2.7Hz,1H),3.75(q,J=2.5Hz,1H),2.05(q,J=2.5Hz,1H),1.02(d,J=34.8Hz,12H). 13 C NMR (101MHz, CDCl3) δ144.91,142.32,136.10,134.96,134.56,132.94,129.75,129.50,128.13,1 28.09,127.87,127.13,125.66,123.93,122.23,83.21,77.37,77.05,76.74,39.91,24.99,24.73. 11 B NMR(128MHz,CDCl3)δ34.17.HRMS(ESI)m / z:[M+Na] + calcd for C 32 H 33 BO2SSiNa +:543.1956; found:543.1961.

[0110] Example 12

[0111] In a nitrogen-filled glove box, 2-((1E,3E)-4-(7-methoxybenzo[d][1,3]dioxo-5-yl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1 L, 0.2 mmol, 66.0 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15-cell atmosphere with a magnetic magnet. The mixture was stirred in a mL pressure-resistant tube at 80℃ for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (20:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound shown in Figure 3L (yellow oil, 2-(7-methoxybenzo[d][1,3]dioxo-5-yl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboro-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 66%. The chemical reaction formula for the above preparation process is as follows:

[0112]

[0113] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.74-7.68(m,2H),7.45-7.37(m,3H),7.24-7.18(m,3H ),7.11(dd,J=8.4,6.5Hz,2H),6.46(d,J=1.5Hz,1H),6.29(dt,J=7.1,2.6Hz ,1H),6.22(d,J=1.5Hz,1H),6.05(dt,J=7.1,2.8Hz,1H),5.85(s,2H),3.69( s,3H),3.63(q,J=2.5Hz,1H),2.01(q,J=2.5Hz,1H),1.02(d,J=32.8Hz,12H). 13 C NMR (101MHz, CDCl3) δ148.57,143.36,137.31,136.10,135.72,134.91,132.68,132.42,132.34,129.74,1 29.53,128.07,127.17,106.45,102.17,101.00,83.23,77.38,77.07,76.75,56.28,40.07,25.00,24.64. 11B NMR(128MHz,CDCl3)δ33.83.HRMS(ESI)m / z:[M+H] + calcd forC 30 H 34 BO5Si + :513.2263; found:513.2268.

[0114] Example 13

[0115] In a nitrogen-filled glove box, 2-((1E,3E)-4-(4-(benzyloxy)phenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1m, 0.2 mmol, 72.4 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15-cell atmosphere with a magnetic magnet. The mixture was stirred in a mL pressure-resistant tube at 40°C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (50:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound shown in 3m (yellow oil, 2-(4-(benzyloxy)phenyl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 42%. The chemical reaction formula for the above preparation process is as follows:

[0116]

[0117] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.74-7.68(m,2H),7.61-7.57(m,1H),7.43-7.34(m, 7H),7.31-7.26(m,2H),7.15-7.11(m,2H),7.08(t,J=7.8Hz,3H),6.82-6.6 9(m,2H),6.28(dt,J=7.0,2.6Hz,1H),6.09(dt,J=7.1,2.7Hz,1H),4.98(s, 2H), 3.66 (q, J=2.5Hz, 1H), 2.01 (q, J=2.5Hz, 1H), 1.00 (d, J=30.0Hz, 12H). 13C NMR (101MHz, CDCl3) δ156.14,137.37,136.16,134.89,132.44,129.62,129.32,128.57,128.51,128. 02,127.80,127.48,127.05,114.67,83.14,77.36,77.24,77.04,76.72,70.07,38.91,24.93,24.74. 11 BNMR(128MHz,CDCl3)δ34.56.HRMS(ESI)m / z:[M+Na] + calcd for C 35 H 37 BO3SiNa + :567.2497; found:567.2500.

[0118] Example 14

[0119] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-3-methyl-4-phenylbut-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1n, 0.2 mmol, 54.0 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was placed in the glove box. The mixture was stirred in a 5 mL pressure-resistant tube at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (50:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3n (colorless oil, 3-methyl-1,1,2-triphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 61%. The chemical reaction formula for the above preparation process is as follows:

[0120]

[0121] The characterization data are: 1H NMR (400MHz, CDCl3) δ7.53-7.44(m,2H),7.36-7.31(m,1H),7.30-7.24(m,5H),7.14(dd,J=7.9,6.8Hz,2H),7.04(t,J=7.5Hz,2H),6.96-6.90( m,1H),6.90-6.81(m,2H),5.98(dq,J=2.8,1.4Hz,1H),3.45(s,1H),2.18(h,J=2.4Hz,1H),1.78(dt,J=2.3,1.0Hz,3H),0.91(d,J=5.0Hz,12H). 13 C NMR (101MHz, CDCl3) δ143.12,141.68,135.98,135.60,135.34,132.74,129.68,129.10,128. 08,127.66,127.62,127.29,124.37,82.88,77.36,77.04,76.72,44.20,24.85,24.47,19.75. 11 B NMR (128MHz, CDCl3)δ

[0122] 34.12.HRMS(ESI)m / z:[M+Na] + calcdfor C 29 H 33 BO2SiNa + :475.2235; found:475.2243.

[0123] Example 15

[0124] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(3,4,5-trimethoxyphenyl)but-1,3-dien-1-yl)-1,3,2-dioxaborane (denoted as 1o, 0.2 mmol, 69.2 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15-meter-high atmosphere with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 80°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (20:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in Figure 3 (yellow oil, 1,1-diphenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-5-(3,4,5-trimethoxyphenyl)-2,5-dihydro-1H-silicon), with a separation yield of 59%. The chemical reaction formula for the above preparation process is as follows:

[0125]

[0126] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.79-7.73(m,2H),7.48-7.40(m,3H),7.23-7.17(m,3H),7.08(dd,J=8.1,7.0Hz,2H),6.34-6 .28(m,3H),6.08(dt,J=7.1,2.7Hz,1H),3.75(s,3H),3.68(s,7H),2.02(q,J=2.6Hz,1H),1.03(d,J=37.1Hz,12H). 13 C NMR (101MHz, CDCl3) δ152.87,138.35,136.03,135.54,135.16,135.00,134.80,132.73,132.39,129. 77,129.54,128.07,127.13,104.74,83.20,77.36,77.04,76.73,60.89,55.99,40.37,25.11,24.55. 11 B NMR(128MHz,CDCl3)δ34.01.HRMS(ESI)m / z:[M+Na] + calcdfor C 31 H 37 BO5SiNa + :551.2396; found:551.2405.

[0127] Example 16

[0128] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(naphth-2-yl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1p, 0.2 mmol, 71.2 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3p (yellow oil, 2-(naphthyl-2-yl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 47%. The chemical reaction formula for the above preparation process is as follows:

[0129]

[0130] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.80-7.74(m,2H),7.73-7.62(m,3H),7.58(d,J=8.5Hz,1H),7.46-7.28(m,6H),7.15-7.06(m,3H),6.99-6.93(m ,2H),6.38(dt,J=7.0,2.6Hz,1H),6.20(dt,J=7.0,2.7Hz,1H),3.89(q,J=2.5Hz,1H),2.09(q,J=2.5Hz,1H),1.01(d,J=30.3Hz,12H). 13 C NMR (101MHz, CDCl3) δ140.32,136.08,135.91,134.96,134.78,133.72,132.96,132.18,131.39,129.74,129.42,128.11,1 27.53,127.49,127.44,127.28,127.04,125.60,125.14,124.45,83.22,77.39,77.07,76.75,40.30,26.95,25.00,24.73. 11 B NMR(128MHz,CDCl3)δ33.93.HRMS(ESI)m / z:[M+Na] + calcd for C 32 H 33 BO2SiNa +:511.2235; found:511.2246.

[0131] Example 17

[0132] In a nitrogen-filled glove box, 2-((1E,3E)-4-(4-(tert-butyl)phenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1q, 0.2 mmol, 62.4 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic field was then placed in the glove box. The mixture was stirred in a mL pressure-resistant tube at 40°C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3q (yellow oil, 2-(4-(tert-butyl)phenyl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 44%. The chemical reaction formula for the above preparation process is as follows:

[0133]

[0134] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.78-7.71(m,2H),7.45-7.39(m,3H),7.17-7.12(m,3H),7.10-6.99(m,6H),6.29(dt,J=7.0,2.5H z,1H),6.12(dt,J=7.1,2.7Hz,1H),3.72(q,J=2.5Hz,1H),2.02(q,J=2.5Hz,1H),1.25(s,9H),1.01(d,J=32.3Hz,12H). 13 CNMR(101MHz, CDCl3)δ147.33,139.32,136.19,136.02,134.99,134.83,132.49,129.65,129.25,128 .04,127.29,126.92,124.91,83.13,77.39,77.08,76.76,39.41,34.22,31.46,26.95,24.97,24.74. 11 B NMR(128MHz,CDCl3)δ34.44.HRMS(ESI)m / z:[M+H] + calcd forC 32 H 40BO2Si + :495.2885; found:495.2885.

[0135] Example 18

[0136] In a nitrogen-filled glove box, 2-((1E,3E)-4-(4-ethylphenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1r, 0.2 mmol, 56.8 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15-cell atmosphere with a magnetic magnet. The mixture was stirred in a mL pressure-resistant tube at 40°C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound shown in 3r (yellow oil, 2-(4-ethylphenyl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 58%. The chemical reaction formula for the above preparation process is as follows:

[0137]

[0138] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.72-7.61(m,2H),7.37-7.32(m,3H),7.12-7.07(m,1H),7.06-6.94(m,6H),6.93-6.85(m,2H),6.22(dt,J=7.0,2.5Hz,1H) ,6.04(dt,J=7.1,2.7Hz,1H),3.63(q,J=2.5Hz,1H),2.46(q,J=7.6Hz,2H ), 1.95 (q, J = 2.5Hz, 1H), 1.08 (t, J = 7.6Hz, 3H), 0.93 (d, J = 33.1Hz, 12H). 13 C NMR (101MHz, CDCl3) δ140.42,139.58,136.19,136.08,135.05,134.97,134.39,132.51,132.42,129.63,129.30, 128.03,127.80,127.66,127.63,127.57,126.98,83.13,77.38,77.07,76.75,39.55,28.41,24.96,24.73,15.90. 11B NMR(128MHz,CDCl3)δ34.64.HRMS(ESI)m / z:[M+Na] + calcd for C 30 H 35 BO2SiNa + :489.2392; found:489.2397.

[0139] Example 19

[0140] In a nitrogen-filled glove box, 2-((1E,3E)-4-(4-fluorophenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1s, 0.2 mmol, 54.8 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3S (yellow oil, 2-(4-fluorophenyl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 38%. The chemical reaction formula for the above preparation process is as follows:

[0141]

[0142] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.72-7.57(m,2H),7.40-7.31(m,3H),7.15-7.10(m,1H),7.07-6.96(m,6H),6.78-6.68(m,2H),6.24 (dt,J=7.1,2.6Hz,1H),6.00(dt,J=7.0,2.8Hz,1H),3.63(q,J=2.5Hz,1H),1.95(q,J=2.5Hz,1H),0.95(d,J=32.0Hz,12H). 13C NMR (101MHz, CDCl3) δ161.74,159.34,138.21,136.04,135.74,134.86,134.50,132.97,132.14,129.72,129. 46,128.86,128.78,128.07,127.10,114.79,114.58,83.21,77.34,77.22,77.02,76.70,39.03,24.96,24.73. 11 B NMR (128MHz, CDCl3)δ

[0143] 34.01. 19 FNMR(376MHz,Chloroform-d)δ-119.59(td,J=8.9,4.4Hz).HRMS(ESI)m / z:[M+H] + calcd for C 28 H 30 BFO2Si + :479.1984; found:479.1988.

[0144] Example 20

[0145] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(4-propoxyphenyl)but-1,3-dien-1-yl)-1,3,2-dioxaborane (denoted as 1t, 0.2 mmol, 62.8 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound shown in Figure 3t (yellow oil, 1,1-diphenyl-2-(4-propoxyphenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 37%. The chemical reaction formula for the above preparation process is as follows:

[0146]

[0147] The characterization data are: 1H NMR (400MHz, CDCl3) δ7.70-7.59(m,2H),7.38-7.30(m,3H),7.14-7.05(m,3H),7.04-6.94(m,4H),6.66-6.57(m,2H),6.21(dt,J=7.1,2.6Hz,1 H), 6.03 (dt, J = 7.1, 2.7Hz, 1H), 3.76 (t, J = 6.7Hz, 2H), 3.58 (q, J = 2.5Hz, 1H), 1.94 (q, J = 2.5Hz, 1H), 1.68 (h, J = 7.1Hz, 2H), 1.02-0.85 (m, 15H). 13 C NMR (101MHz, CDCl3) δ156.44,136.18,135.20,134.90,134.40,132.51,132.31,129.60,129.32,128 .55,128.01,127.05,114.34,83.14,77.37,77.05,76.74,69.58,38.91,24.93,24.75,22.65,10.56. 11 B NMR(128MHz,CDCl3)δ34.44.HRMS(ESI)m / z:[M+Na] + calcd for C 31 H 37 BO3SiNa + :519.2497; found:519.2513.

[0148] Example 21

[0149] In a nitrogen-filled glove box, 2-((1E,3E)-4-(3,4-dimethoxyphenyl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1u, 0.2mmol, 63.2mg), diphenyldichlorosilane (denoted as 2a, 0.4mmol, 101.3mg), and magnesium powder (0.4mmol, 9.6mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15-cell atmosphere with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 80°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (50:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in Figure 3 (yellow oil, 2-(3,4-dimethoxyphenyl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 53%. The chemical reaction formula for the above preparation process is as follows:

[0150]

[0151] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.73-7.61(m,2H),7.41-7.32(m,3H),7.17-7.09(m,3H),7.01 (dd,J=8.2,6.9Hz,2H),6.68(dd,J=8.2,2.0Hz,1H),6.61(d,J=8.2Hz,1H),6.46(d, J=2.0Hz,1H),6.23(dt,J=7.0,2.6Hz,1H),6.01(dt,J=7.0,2.7Hz,1H),3.73(s,3H) ,3.63(q,J=2.6Hz,1H),3.56(s,3H),1.95(q,J=2.6Hz,1H),0.95(d,J=38.4Hz,12H). 13 C NMR (101MHz, CDCl3) δ148.63,146.18,136.09,135.74,135.33,135.19,135.01,132.57,132.35,129.70,129. 49,128.05,127.16,119.51,111.12,111.01,83.18,77.38,77.06,76.74,55.91,55.63,39.44,25.07,24.61. 11 B NMR(128MHz,CDCl3)δ33.49.HRMS(ESI)m / z:[M+Na] + calcd for C 30 H 35 BO4SiNa + :521.2290; found:521.2308.

[0152] Example 22

[0153] In a nitrogen-filled glove box, 2-((1E,3E)-4-(bicyclo[4.2.0]octane-1(6),2,4-trien-3-yl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxoborane (denoted as 1w, 0.2mmol, 56.4mg), diphenyldichlorosilane (denoted as 2a, 0.4mmol, 101.3mg) and magnesium powder (0.4mmol, 9.6mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic spool was then placed in a 15 mL container. The mixture was stirred in a pressure-resistant tube for 20 hours at 40°C. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound shown in Figure 3w (yellow oil, 2-(bicyclo[4.2.0]octane-1(6),2,4-trien-3-yl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 41%. The chemical reaction formula for the above preparation process is as follows:

[0154]

[0155] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.70-7.60 (m, 2H), 7.34 (dtt, J = 8.6, 4.6, 2.2Hz, 3H), 7.14-7. 06(m,3H),7.00(t,J=7.3Hz,2H),6.93(dd,J=7.5,1.5Hz,1H),6.83(s,1H),6.74(d, J=7.5Hz,1H),6.21(dt,J=7.1,2.6Hz,1H),6.03(dt,J=7.0,2.7Hz,1H),3.62(q,J=2 .5Hz,1H),2.97(hept,J=4.8Hz,4H),1.95(q,J=2.5Hz,1H),0.93(d,J=31.0Hz,12H). 13 C NMR (101MHz, CDCl3) δ145.54,141.72,141.00,136.24,135.36,134.92,132.28,129.59,129.30,128. 00,126.98,126.31,122.12,122.03,83.13,77.37,77.05,76.73,40.54,29.24,29.15,24.91,24.73. 11 B NMR(128MHz,CDCl3)δ34.14.HRMS(ESI)m / z:[M+Na] +calcd for C 30 H 33 BO2SiNa + :487.2235; found:487.2243.

[0156] Example 23

[0157] In a nitrogen-filled glove box, 2-((1E,3E)-4-(2,3-dihydro-1H-inden-5-yl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxoborane (denoted as 1x, 0.2 mmol, 59.2 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was then placed in a 15 mL... The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in 3x (yellow oil, 2-(2,3-dihydro-1H-inden-5-yl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 49%. The chemical reaction formula for the above preparation process is as follows:

[0158]

[0159] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.69-7.63(m,2H),7.37-7.31(m,3H),7.12-7.06(m,3H),7.01-6.95(m,3H),6.93-6.86(m,2H),6.21(dt,J=7.1,2 .6Hz,1H),6.03(dt,J=7.1,2.7Hz,1H),3.62(q,J=2.5Hz,1H),2.67(dq,J=26.9,7.8Hz,4H),1.97-1.86(m,3H),0.93(d,J=30.5Hz,12H). 13 C NMR (101MHz, CDCl3) δ144.10,140.27,140.14,136.24,135.41,134.94,132.21,129.59,129.28,128 .01,126.95,125.66,123.83,83.12,77.38,77.06,76.75,39.80,32.79,32.39,25.56,24.94,24.72.11 B NMR(128MHz,CDCl3)δ34.48.HRMS(ESI)m / z:[M+Na] + calcd for C 31 H 35 BO2SiNa + :501.2392; found:501.2398.

[0160] Example 24

[0161] In a nitrogen-filled glove box, 2-((1E,3E)-4-(furan-2-yl)but-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxoborane (denoted as 1y, 0.2 mmol, 49.2 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 80°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3y (yellow oil, 2-(furan-2-yl)-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxobor-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 45%. The chemical reaction formula for the above preparation process is as follows:

[0162]

[0163] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.88-7.76(m,2H),7.42-7.36(m,3H),7.17-7.11(m,3H),7.07-6.99(m,3H),6.19(dt,J=7.1,2.6Hz,1H) ,6.12-6.05(m,2H),5.83(dt,J=3.2,1.0Hz,1H),3.70(dt,J=3.6,2.6Hz,1H),1.96(q,J=2.6Hz,1H),0.88(d,J=38.6Hz,12H). 13 C NMR (101MHz, CDCl3)δ

[0164] 156.02,140.03,135.54,135.31,133.01,131.80,129.79,129.52,128.11,127.06,110.18,103.40,83.13,77.35,77.04,76.72,32.93,24.95,24.50. 11 B NMR(128MHz,CDCl3)δ33.32.HRMS(ESI)m / z:[M+Na] + calcd for C 26 H 29 BO3SiNa + :451.1871; found:451.1878.

[0165] Example 25

[0166] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-6-phenylhexa-1,3-dien-1-yl)-1,3,2-dioxaborane (denoted as 1aa, 0.2 mmol, 56.8 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), trichlorotitanene (0.02 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was stirred in a 15 mL pressure-resistant tube with a magnetic magnet for 20 h at 40 °C. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3aa (colorless oil, 2-phenylethyl-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 38%. The chemical reaction formula for the above preparation process is as follows:

[0167]

[0168] The characterization data are: 1¹H NMR (400 MHz, CDCl₃) δ 7.72-7.66 (m, 2H), 7.42-7.35 (m, 5H), 7.29-7.24 (m, 1H), 7.18 (dd, J=7.9, 6.7 Hz, 3H), 7.11-7.06 (m, 2H), 7.04-6.99 (m, 1H), 6.80-6.71 (m, 2H), 6.01 (dt, J=7.0, 2.4 Hz, 1H), 5.95 (dt, J=7.0, 2.6 Hz, 1H), 2.60 (ddd, J=13.1, 11.0, 5.3 Hz, 1H), 2.38 (ddd, J=13.1, 11.0, 5.5 Hz, 1H), 2.29 (ddq, J=9.6, 7.4, 2.6 Hz, 1H), 1.89-1.79 (m, 2H), 1.61 (dddd, J=13.3, 11.1, 9.2, 5.5 Hz, 1H), 0.99 (s, 6H), 0.82 (s, 6H). 13 ¹³C NMR (101 MHz, CDCl₃) δ 142.61, 136.96, 135.83, 135.44, 135.17, 133.66, 130.57, 129.65, 129.56, 128.30, 128.16, 128.05, 127.42, 125.56, 83.02, 77.36, 77.24, 77.04, 76.72, 36.90, 33.26, 30.49, 25.21, 24.35. 11 ¹¹B NMR (128 MHz, CDCl₃) δ 34.19. HRMS (ESI) m / z: [M+K] + calcd for C 30 H 35 BKO₂Si + : 505.2131; found: 505.2144.

[0169] Example 26

[0170] In a nitrogen-filled glove box, 2-((1E,3E)-hept-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1ab, 0.2 mmol, 44.4 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), trichlorotitanene (0.02 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was stirred in a 15 mL pressure-resistant tube with a magnetic magnet for 20 h at 40 °C. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (150:1) as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound shown in 3ab (colorless oil, 1,1-diphenyl-2-propyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 56%. The chemical reaction formula for the above preparation process is as follows:

[0171]

[0172] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.74-7.68(m,2H),7.38-7.33(m,5H),7.23-7.20(m,1H),7.18 -7.14(m,2H),5.96(tdd,J=9.7,7.1,2.5Hz,2H),2.21(ddq,J=7.7,5.0,2.5Hz,1H), 1.79(q,J=2.5Hz,1H),1.52-1.44(m,1H),1.34(dddd,J=11.9,9.8,5.7,2.5Hz,2H), 1.16(ddt,J=14.7,5.8,3.7Hz,1H),0.97(s,6H),0.81(s,6H),0.69(t,J=7.0Hz,3H). 13 C NMR (101MHz, CDCl3) δ137.39,135.76,135.43,130.08,129.47,127.99,127 .25,82.94,77.36,77.04,76.72,32.95,30.58,25.18,24.35,23.65,14.23. 11 B NMR(128MHz,CDCl3)δ34.62.HRMS(ESI)m / z:[M+H] + calcd for C 25 H 34 BO2Si +:405.2416; found:405.2433.

[0173] Example 27

[0174] In a nitrogen-filled glove box, 2-((1E,3E)-4-cyclohexylbutyl-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1ac, 0.2 mmol, 52.4 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), trichlorotitanium (0.02 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of dimethyl ethylene glycol. The mixture was stirred in ether in a 15 mL pressure-resistant tube with a magnetic stir bar at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (150:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3ac (colorless oil, 2-cyclohexyl-1,1-diphenyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,5-dihydro-1H-silicon), with a separation yield of 31%. The chemical reaction formula for the above preparation process is as follows:

[0175]

[0176] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.80-7.71(m,2H),7.37(ddd,J=6.4,3.7,2.4Hz,5H),7.17-7.10(m,3H),6.11(dt,J=7.2,2.7Hz,1H),6.04-5.97(m,1H) ,2.03(dp,J=10.9,2.8Hz,2H),1.73(q,J=2.7Hz,1H),1.60(ddd,J=9.3,4.8,2.5Hz,1H),1.47-1.26(m,4H),1.08-0.87(m,11H),0.79(s,6H). 13 CNMR(101MHz, CDCl3)δ137.21,135.74,135.59,135.54,134.85,134.54,134.46,134.37,130.63,129.37,127.92,127.6 9,127.65,127.61,127.22,82.90,77.36,77.05,76.73,38.26,38.21,35.37,33.73,26.60,26.55,26.47,25.22,24.30. 11B NMR(128MHz,CDCl3)δ33.13.HRMS(ESI)m / z:[M+Na] + calcd forC 28 H 37 BO2SiNa + :467.2548; found:467.2555.

[0177] Example 28

[0178] In a nitrogen-filled glove box, (E)-2-(2-(cyclopent-1-en-1-yl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1ad, 0.2 mmol, 44.0 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), trichlorotitanthane (0.02 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was stirred in a 15 mL pressure-resistant tube with a magnetic stir bar at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (150:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3ad (colorless oil, 1,1-diphenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaboron-2-yl)-1,2,4,5,6,6a-hexahydrocyclopentane[b]silicon), with a separation yield of 34%. The chemical reaction formula for the above preparation process is as follows:

[0179]

[0180] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.85-7.61(m,2H),7.40-7.37(m,3H),7.35-7.32(m,2H),7.23-7.20(m,1H),7.17-7.12(m,2H),5.67(dq,J=3.5,1.8Hz ,1H),2.40(tdp,J=8.5,3.2,1.5Hz,1H),2.27-2.10(m,3H),1.84-1.72(m,3H),1.32(tdd,J=11.7,8.8,4.2Hz,1H),0.90(d,J=32.6Hz,12H). 13CNMR(101MHz,CDCl3)δ155.59,135.54,135.50,134.36,133.76,129.54,129.46,127.91,12 7.26,117.66,82.81,77.34,77.23,77.02,76.71,35.29,29.36,28.30,25.86,25.08,24.35. 11 B NMR (128MHz, CDCl3)δ

[0181] 34.00.HRMS(ESI)m / z:[M+Na] + calcdfor C 25 H 31 BO2SiNa + :425.2079; found:425.2089.

[0182] Example 29

[0183] In a nitrogen-filled glove box, (E)-2-(2-(cyclohex-1-en-1-yl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1ae, 0.2 mmol, 46.8 mg), diphenyldichlorosilane (denoted as 2a, 0.4 mmol, 101.3 mg), trichlorotitanene (0.02 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic precipitator was then placed in the atmosphere. The mixture was placed in a 15 mL pressure-resistant tube and stirred at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (150:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3ae (colorless oil, 1,1-diphenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,4,5,6,7,7a-hexahydro-1H-benzo[b]silicon), with a separation yield of 52%. The chemical reaction formula for the above preparation process is:

[0184]

[0185] The characterization data are: 1H NMR (400MHz, CDCl3) δ7.74-7.63(m,2H),7.39-7.33(m,5H),7.18-7.13(m,3H),5.63(q,J=2.2Hz,1H),2.53-2.45(m,1H) ,2.05(ddt,J=12.2,5.1,2.4Hz,1H),1.98-1.88(m,1H),1.77-1.63(m,4H),1.29-1.18(m,3H),0.97(s,6H),0.80(s,6H). 13 CNMR(101MHz,CDCl3)δ146.33,135.95,135.24,129.46,129.39,128.00,127.24,12 2.20,82.85,77.36,77.05,76.73,32.74,30.23,28.24,27.34,26.74,25.21,24.25. 11 B NMR(128MHz,CDCl3)δ34.46.HRMS(ESI)m / z:[M+Na] + calcd for C 26 H 33 BO2SiNa + :439.2235; found:439.2241.

[0186] Example 30

[0187] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-6-phenylhexa-1,3-dien-1-yl)-1,3,2-dioxaborane (denoted as 1ba, 0.2 mmol, 56.8 mg), 1,1-dichlorosilylcyclobutane (denoted as 4a, 0.4 mmol, 56.4 mg), trichlorotitanthoctane (0.02 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. In dimethyl ether, the mixture was placed in a 15 mL pressure-resistant tube with a magnetic magnet and stirred at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (150:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3ba (colorless oil, 5-phenylethyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-4-siloxoethyl[3,4]oct-6-ene), with a separation yield of 54%. The chemical reaction formula of the above preparation process is as follows:

[0188]

[0189] The characterization data are:1 H NMR (400MHz, CDCl3) δ7.24-7.18(m,2H),7.15-7.07(m,3H),5.90(dt,J=7.2,2.4Hz,1H),5.82(ddd,J=7.1,2.6 ,1.7Hz,1H),2.72-2.59(m,2H),2.15-1.99(m,2H),1.89-1.68(m,3H),1.54-1.48(m,2H),1.24-1.14(m,16H). 13 C NMR (101MHz, CDCl3) δ142.82,135.44,130.01,128.45,128.30,125.66,83.14,77. 34,77.23,77.03,76.71,36.08,33.14,30.76,25.03,24.97,18.41,15.95,13.26. 11 BNMR(128MHz,CDCl3)δ33.27.HRMS(ESI)m / z:[M+Na] + calcd for C 21 H 31 BO2SiNa + :377.2079; found:377.2085.

[0190] Example 31

[0191] In a nitrogen-filled glove box, 2-((1E,3E)-hept-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1bb, 0.2 mmol, 44.4 mg), 1,1-dichlorosilylcyclobutane (denoted as 4a, 0.4 mmol, 56.4 mg), trichlorotitanthoctane (0.02 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of dimethyl ethylene glycol. The mixture was stirred in ether in a 15 mL pressure-resistant tube with a magnetic magnet for 20 h at 40 °C. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (150:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3bb (colorless oil, 5-propyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-4-siloxopyrrole[3,4]oct-6-ene), with a separation yield of 61%. The chemical reaction formula of the above preparation process is as follows:

[0192]

[0193] The characterization data are: 1H NMR (400MHz, CDCl3) δ5.84 (dt, J=7.2, 2.7Hz, 1H), 5.77 (dt, J=7.1, 2.4Hz, 1H), 2.12-1.98 (m, 2H) ,1.75(tdt,J=7.3,3.4,1.8Hz,1H),1.46-1.34(m,4H),1.22-1.11(m,17H),0.86(t,J=7.0Hz,3H). 13 C NMR (101MHz, CDCl3) δ136.05,129.37,83.07,77.34,77.02,76.70,33.39,31.00,25.01,24.95,22.98,18.34,15.91,14.29,13.17. 11 B NMR(128MHz,CDCl3)δ33.44.HRMS(ESI)m / z:[M+H] + calcd for C 16 H 30 BO2Si + :293.2103; found:293.2111.

[0194] Example 32

[0195] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E,5E)-non-1,3,5-trien-1-yl)-1,3,2-dioxoborane (denoted as 1bc, 0.2 mmol, 49.6 mg), 1,1-dichlorosilylcyclobutane (denoted as 4a, 0.4 mmol, 56.4 mg), trichlorotitanene (0.02 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was stirred in a 15 mL pressure-resistant tube with a magnetic magnet for 20 h at 40 °C. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (150:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3bc (colorless oil, (5-pent-1-en-1-yl)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborhexacyclopent-2-yl)-4-silazone[3.4]oct-6-ene), with a separation yield of 46%. The chemical reaction formula of the above preparation process is as follows:

[0196]

[0197] The characterization data are: 1H NMR (400MHz, CDCl3) δ5.86(dt,J=7.1,2.4Hz,1H),5.77(dt,J=7.1,2.7Hz,1H),5.39(ddt,J=15.3,8.2,1.3Hz,1H),5.31-5.23(m,1H),2.60(d, J=8.4Hz,1H),2.06(dddt,J=15.2,13.7,10.3,6.8Hz,2H),1.96-1.88(m,3H),1.33-1.25(m,3H),1.17(d,J=6.4Hz,15H),0.81(t,J=7.4Hz,3H). 13 C NMR (101MHz, CDCl3) δ134.13,130.69,129.90,127.64,83.12,77.33,77.2 1,77.01,76.69,35.98,34.90,24.94,23.04,18.00,16.14,13.67,13.58. 11 B NMR(128MHz,CDCl3)δ33.77.HRMS(ESI)m / z:[M+Na] + calcd forC 18 H 31 BO2SiNa + :341.2079; found:341.2087.

[0198] Example 33

[0199] In a nitrogen-filled glove box, 2-((1E,3E)-dodecane-1,3-dien-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxoborane (denoted as 1bd, 0.2 mmol, 58.4 mg), 1,1-dichlorosilylcyclobutane (denoted as 4a, 0.4 mmol, 56.4 mg), trichlorotitanthoctane (0.04 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. In dimethyl ether, the mixture was placed in a 15 mL pressure-resistant tube with a magnetic magnet and stirred at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (150:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3bd (colorless oil, 5-octyl-8-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-4-siloxane[3.4]octyl-6-ene), with a separation yield of 51%. The chemical reaction formula of the above preparation process is as follows:

[0200]

[0201] The characterization data are: 1 H NMR(400MHz, CDCl3)δ5.80(ddt,J=26.1,7.1,2.5Hz,2H),2.12-1.99(m,2H),1.73(td t,J=7.3,3.4,1.9Hz,1H),1.53-1.42(m,3H),1.24-1.14(m,28H),0.83-0.79(m,3H). 13 C NMR (101MHz, CDCl3) δ136.12,129.35,83.06,77.34,77.02,76.70,31.91,31.24,31 .12,29.90,29.85,29.58,29.36,25.00,24.96,22.69,18.35,15.93,14.11,13.23. 11 B NMR(128MHz,CDCl3)δ33.20.HRMS(ESI)m / z:[M+H] + calcd for C 21 H 40 BO2Si + :363.2885; found:363.2885.

[0202] Example 34

[0203] In a nitrogen-filled glove box, (E)-2-(2-(cyclopent-1-en-1-yl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1be, 0.2 mmol, 44.0 mg), 1,1-dichlorosilylcyclobutane (denoted as 4a, 0.4 mmol, 56.4 mg), trichlorotitanthane (0.04 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was stirred in a 15 mL pressure-resistant tube at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (150:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3be (colorless oil, 2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-4,5,6,6a-tetrahydro-2H-spiro[cyclopenta[b]silane-1,1'-silane]), with a separation yield of 53%. The chemical reaction formula for the above preparation process is as follows:

[0204]

[0205] The characterization data are: 1H NMR (400MHz, CDCl3) δ5.41 (dq, J=3.6, 1.8Hz, 1H), 2.18-1.90 (m, 6H), 1.77 (dddd, J=12.6, 7.0, 5.5, 3.0Hz, 4H), 1.21 (s, 16H). 13 C NMR (101MHz, CDCl3) δ154.75,116.27,82.91,77.33,77.01,76.70,35.93,28.78,28.16,25.98,25.14,24.80,17.83,14.91,13.02. 11 B NMR(128MHz,CDCl3)δ33.41.HRMS(ESI)m / z:[M+H] + calcd forC 16 H 28 BO2Si + 291.1946; found: 291.1953.

[0206] Example 35

[0207] In a nitrogen-filled glove box, (E)-2-(2-(cyclohex-1-en-1-yl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborane (denoted as 1bf, 0.2 mmol, 46.8 mg), 1,1-dichlorosilylcyclobutane (denoted as 4a, 0.4 mmol, 56.4 mg), trichlorotitanene (0.02 mmol, 4.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was stirred in a 15 mL pressure-resistant tube at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (150:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 3bf (colorless oil, 2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-2,4,5,6,7,7a-hexahydrospiro[benzo[b]silane-1,1'-silane]), with a separation yield of 37%. The chemical reaction formula for the above preparation process is as follows:

[0208]

[0209] The characterization data are: 1H NMR (400MHz, CDCl3) δ5.35 (dq, J=7.6, 2.2Hz, 1H), 2.39-2.28 (m, 1H), 2.08 (tddd, J=9.7, 7.9, 4.3, 2.3Hz, 1H), 1.89 (ddddd ,J=19.2,12.2,8.3,5.7,3.1Hz,3H),1.71(tdd,J=11.4,5.5,3.5Hz,2H),1.61-1.44(m,3H),1.17(dd,J=10.0,5.7Hz,18H). 13 C NMR (101MHz, CDCl3) δ146.29,120.43,82.89,77.33,77.01,76.70,32.75,31.39,28.80,27.66,27.29,25.02,24.96,18.54,15.35,12.98. 11 BNMR(128MHz,CDCl3)δ34.24.HRMS(ESI)m / z:[M+H] + calcd for C 17 H 30 BO2Si + :305.2103; found:305.2116.

[0210] Example 36

[0211] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), 1,1-dichlorosilylcyclobutane (denoted as 4a, 0.4 mmol, 56.4 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was then placed in the glove box. The mixture was stirred in a 5 mL pressure-resistant tube at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound shown in 5a (colorless oil, 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborane-2-yl)-8-(p-tolyl)-4-siloxane[3.4]oct-6-ene), with a separation yield of 53%. The chemical reaction formula for the above preparation process is as follows:

[0212]

[0213] The characterization data are: 1H NMR (400MHz, CDCl3) δ7.10-6.98(m,4H),6.09(dt,J=7.1,2.5Hz,1H),5.97(dt,J=7.1,2.7Hz,1H),3.30(q,J=2.3Hz,1H),2.29(s,3H),2.1 0-2.00(m,1H),1.90-1.79(m,1H),1.67(q,J=2.3Hz,1H),1.40-1.30(m,2H),1.24(d,J=5.0Hz,12H),1.08-0.98(m,1H),0.66-0.55(m,1H). 13 CNMR(101MHz,CDCl3)δ139.84,134.15,133.67,131.98,128.98,126.94,83 .22,77.36,77.05,76.73,39.62,25.07,24.94,20.96,17.96,16.19,13.64. 11 B NMR(128MHz,CDCl3)δ33.06.HRMS(ESI)m / z:[M]calcd for C 20 H 29 BO2Si:340.2030; found:340.2033.

[0214] Example 37

[0215] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), 1,1-dichlorosilylcyclopentane (denoted as 4b, 0.4 mmol, 62.0 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was then placed in the glove box. The mixture was stirred in a 5 mL pressure-resistant tube at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound shown in 5b (colorless oil, 1-(4,4,5,5-tetramethyl-1,3,2-dioxaborane-2-yl)-4-(p-tolyl)-5-siloxane[4.4]non-2-ene), with a separation yield of 48%. The chemical reaction formula for the above preparation process is as follows:

[0216]

[0217] The characterization data are: 1H NMR (400MHz, CDCl3) δ7.04-7.01(m,2H),6.99-6.93(m,2H),6.10(dt,J=7.0,2.5Hz,1H),5.96(dt,J=7.0,2.7Hz,1H),3.18(q,J=2.4Hz, 1H),2.29(s,3H),1.54(q,J=2.3Hz,1H),1.52-1.43(m,2H),1.23(s,14H),0.87(q,J=6.9Hz,2H),0.50-0.42(m,1H),0.12-0.05(m,1H). 13 C NMR (101MHz, CDCl3) δ140.58,134.41,133.46,132.65,128.93,126.77,83.08 ,77.36,77.04,76.72,38.68,26.88,26.81,25.07,25.00,20.95,12.56,8.72. 11 B NMR(128MHz,CDCl3)δ35.10.HRMS(ESI)m / z:[M]calcd for C 21 H 31 BO2Si:354.2186; found:354.2185.

[0218] Example 38

[0219] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), 1,1-dichlorosilylcyclohexane (denoted as 4c, 0.4 mmol, 67.6 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was then placed in the glove box. The mixture was stirred in a 5 mL pressure-resistant tube at 40 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography. Petroleum ether / ethyl acetate (100:1) was used as the eluent, and the solvent was evaporated under reduced pressure to obtain the compound shown in 5c (colorless oil, 1-(4,4,5,5-tetramethyl-1,3,2-dioxaboran-2-yl)-4-(p-tolyl)-5-siloxane[4.5]dec-2-ene), with a separation yield of 52%. The chemical reaction formula for the above preparation process is:

[0220]

[0221] The characterization data are: 1H NMR (400MHz, CDCl3) δ7.00-6.91 (m, 4H), 6.00 (ddd, J = 7.0, 2.9, 2.1Hz, 1H), 5.84 (ddd ,J=7.0,3.2,2.2Hz,1H),3.01(dt,J=3.4,1.6Hz,1H),2.22(s,3H),1.81-1.74(m,1H), 1.64-1.48(m,3H),1.29(td,J=2.6,1.4Hz,1H),1.17(s,14H),0.78(ddt,J=11.2,9.8 ,4.5Hz,2H),0.41(ddd,J=14.8,10.3,4.7Hz,1H),0.20(ddd,J=14.6,7.5,4.0Hz,1H). 13 C NMR (101MHz, CDCl3) δ140.35,134.00,133.41,132.74,128.74,127.21,83.06,38.18,29.47,25.21,24.95,24.78,24.38,20.98,13.77,10.25. 11 B NMR(128MHz,CDCl3)δ34.04.HRMS(ESI)m / z:[M]calcd for C 22 H 33 BO2Si:368.2343; found:368.2351.

[0222] Example 39

[0223] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), bis(4-(tert-butyl)phenyl)dichlorosilane (denoted as 4d, 0.4 mmol, 145.6 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 80°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in d (colorless oil, 1,1-bis(4-(tert-butyl)phenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaboron-2-yl)-5-(p-tolyl)-2,5-dihydro-1H-silicon), with a separation yield of 33%. The chemical reaction formula for the above preparation process is as follows:

[0224]

[0225] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.64-7.56(m,2H),7.39-7.34(m,2H),7.04-6.95(m,6H),6.89(d,J=7.8Hz,2H),6.19(dt,J=7.1,2.6Hz,1H),6.0 2(dt,J=7.0,2.7Hz,1H),3.60(q,J=2.5Hz,1H),2.19(s,3H),1.93(q,J=2.5Hz,1H),1.28(s,9H),1.12(s,9H),0.87(d,J=31.8Hz,12H). 13 C NMR (101MHz, CDCl3) δ152.43,152.14,139.64,136.05,135.13,134.81,133.66,132.72,132.40,129.15,128.76,12 7.67,124.95,123.93,82.97,77.36,77.25,77.04,76.73,39.72,34.76,34.53,31.29,31.12,24.85,24.66,20.97. 11 BNMR(128MHz,CDCl3)δ34.57.HRMS(ESI)m / z:[M+Na] + calcd for C 37 H 49 BO2SiNa + :587.3487; found:587.3499.

[0226] Example 40

[0227] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), dichlorodi-p-tolylsilane (denoted as 4e, 0.4 mmol, 112.0 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was then placed in the solution. The mixture was stirred in a 15 mL pressure-resistant tube at 80 °C for 20 h. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound with the structure shown in 5e (colorless oil, 2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-1,1,5-tris-p-tolyl-2,5-dihydro-1H-silicon), with a separation yield of 46%. The chemical reaction formula for the above preparation process is as follows:

[0228]

[0229] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.57-7.47(m,2H),7.16-7.13(m,2H),7.00-6.93(m,4H),6.86(d,J=7.9Hz,2H),6.80(d,J=7.6Hz,2H),6.19(dt,J=7.1,2.6 Hz,1H),6.01(dt,J=7.0,2.7Hz,1H),3.56(q,J=2.5Hz,1H),2.30(s,3H),2.14(d,J=14.2Hz,6H),1.91(q,J=2.5Hz,1H),0.93(d,J=30.2Hz,12H). 13 C NMR (101MHz, CDCl3) δ139.57,139.46,139.06,136.22,135.11,134.95,133.70,132.77,132.39,128.93, 128.83,128.76,127.82,127.66,83.07,77.39,77.08,76.76,39.72,24.93,24.76,21.62,21.49,20.98. 11 B NMR(128MHz,CDCl3)δ34.07.HRMS(ESI)m / z:[M+Na] + calcd for C 31 H 37 BO2SiNa +:503.2548; found:503.2640.

[0230] Example 41

[0231] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), dibutylsilicon dichloride (denoted as 4f, 0.4 mmol, 85.3 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in 5f (colorless oil, 1,1-dibutyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-5-(p-tolyl)-2,5-dihydro-1H-silicon), with a separation yield of 57%. The chemical reaction formula for the above preparation process is as follows:

[0232]

[0233] The characterization data are: 1 H NMR (400MHz, CDCl3) δ6.93 (s, 4H), 5.98 (dt, J = 6.9, 2.5Hz, 1H), 5.83 (ddd, J = 7.0, 3.1, 2.3Hz, 1H), 3.01 (dt, J = 3.5, 1. 8Hz,1H),2.21(s,3H),1.34-1.27(m,7H),1.17(s,12H),0.87-0.80(m,6H),0.73-0.67(m,3H),0.57(t,J=7.2Hz,3H). 13 C NMR (101MHz, CDCl3) δ140.48,134.08,133.37,132.87,128.68,127.09,82.96,77.34,77. 02,76.71,37.79,26.60,26.55,25.96,25.19,24.95,20.91,13.81,13.46,13.37,11.28. 11 BNMR(128MHz,CDCl3)δ34.52.HRMS(ESI)m / z:[M+Na] + calcd for C 25 H 41 BO2SiNa +:435.2861; found:435.2867.

[0234] Example 42

[0235] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), di-n-propylsilicon dichloride (denoted as 4 g, 0.4 mmol, 74.1 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain 5 g of the compound with the shown structure (colorless oil, 1,1-dipropyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-5-(p-tolyl)-2,5-dihydro-1H-silicon), with a separation yield of 52%. The chemical reaction formula for the above preparation process is as follows:

[0236]

[0237] The characterization data are: 1 H NMR (400MHz, CDCl3) δ6.79(s,4H),5.83(ddd,J=7.0,2.8,2.2Hz,1H),5.68(ddd,J=7.0,3.2,2.3Hz,1H),2.87(dt,J=3.5,1.8Hz,1H),1.2 5-1.19(m,2H),1.16(q,J=2.3Hz,1H),1.02(s,14H),0.79(t,J=7.2Hz,3H),0.58-0.53(m,2H),0.46(t,J=7.2Hz,3H),0.19--0.01(m,2H). 13 C NMR (101MHz, CDCl3) δ140.47,134.06,133.36,132.86,128.69,127.09,82.96,77.34, 77.03,76.71,37.84,25.18,24.96,20.94,18.39,18.30,17.39,16.72,16.41,14.20. 11 B NMR(128MHz,CDCl3)δ33.38.HRMS(ESI)m / z:[M+Na] + calcd for C 23 H 37BO2SiNa + :407.2548; found:407.2552.

[0238] Example 43

[0239] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), diisopropylsilicon dichloride (denoted as 4h, 0.4 mmol, 74.1 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was then placed in the 15 mL of the glove box. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. The solvent was then evaporated under reduced pressure to obtain the compound with the structure shown in the figure (colorless oil, 1,1-diisopropyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-5-(p-tolyl)-2,5-dihydro-1H-silicon), with a separation yield of 38%. The chemical reaction formula for the above preparation process is as follows:

[0240]

[0241] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.04-7.00(m,2H),6.96-6.92(m,2H),5.97(dt,J=7.0,2.5Hz,1H),5.86(dt,J=7.0,2.8Hz,1H),3.10(dt,J=3.4,2.0Hz ,1H),2.21(s,3H),1.34(q,J=2.4Hz,1H),1.18(s,12H),1.05(d,J=6.5Hz,3H),1.02-0.95(m,6H),0.76(p,J=2.5Hz,3H),0.61-0.59(m,2H). 13 CNMR (101MHz, CDCl3) δ140.40,134.34,133.46,132.69,128.66,127.59,83.00,77.34 ,77.03,76.71,35.96,25.15,25.01,20.94,18.55,18.35,18.16,17.84,12.10,11.85. 11 B NMR(128MHz,CDCl3)δ34.70.HRMS(ESI)m / z:[M]calcd for C 23 H37 BO2Si:384.2656; found:384.2650.

[0242] Example 44

[0243] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), dimethyl silicon dichloride (denoted as 4i, 0.4 mmol, 52.0 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. A magnetic osmosis magnet was then placed in the 15 mL of the glove box. The mixture was stirred in a pressure-resistant tube at 40°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (100:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in Figure 5i (colorless oil, 1,1-dimethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-5-(p-tolyl)-2,5-dihydro-1H-silicon), with a separation yield of 67%. The chemical reaction formula for the above preparation process is as follows:

[0244]

[0245] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.29-7.25(m,2H),7.24-7.17(m,2H),6.31(dt,J=7.0,2.5Hz,1H),6.17(dt ,J=7.0,2.7Hz,1H),3.31(q,J=2.4Hz,1H),2.53(s,3H),1.63(s,1H),1.47(s,12H),0.55(s,3H). 13 C NMR (101MHz, CDCl3) δ141.63,135.25,134.59,133.69,130.01,127.86,84.18,78.53,78.21,77.89,40.76,26.22,26.18,22.11,0.00,-3.36. 11 B NMR(128MHz,CDCl3)δ33.28.HRMS(ESI)m / z:[M]calcd for C 19 H 29 BO2Si:328.2030; found:328.2035.

[0246] Example 45

[0247] In a nitrogen-filled glove box, 4,4,5,5-tetramethyl-2-((1E,3E)-4-(p-tolyl)but-1,3-dien-1-yl)-1,3,2-dioxoborane (denoted as 1b, 0.2 mmol, 54.0 mg), dichlorobis(3-methoxyphenyl)silane (denoted as 4j, 0.4 mmol, 124.8 mg), and magnesium powder (0.4 mmol, 9.6 mg) were placed in 1 mL of ethylene glycol dimethyl ether. The mixture was then placed in a 15 mL container with a magnetic magnet. The mixture was stirred in a pressure-resistant tube at 80°C for 20 hours. The resulting reaction solution was purified by silica gel column chromatography using petroleum ether / ethyl acetate (30:1) as the eluent. After elution, the solvent was evaporated under reduced pressure to obtain the compound shown in Figure 5j (a yellow solid, 1,1-bis(3-methoxyphenyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxoboron-2-yl)-5-(p-tolyl)-2,5-dihydro-1H-silicon), with a separation yield of 59%. The chemical reaction formula for the above preparation process is as follows:

[0248]

[0249] The characterization data are: 1 H NMR (400MHz, CDCl3) δ7.27(t,J=7.7Hz,1H),7.21(dt,J=7.1,1.6Hz,2H),7.07-7.02(m,2H),6.95(dd,J =8.2,7.3Hz,1H),6.89(dd,J=8.4,3.5Hz,3H),6.76(dt,J=7.2,1.1Hz,1H),6.66(ddd,J=8.2,2.8,1.0Hz ,1H),6.49(dd,J=2.7,0.9Hz,1H),6.22(dt,J=7.1,2.6Hz,1H),6.02(dt,J=7.1,2.7Hz,1H),3.74(s,3H) ,3.59(dt,J=4.7,2.3Hz,1H),3.42(s,3H),2.17(s,3H),1.95(q,J=2.4Hz,1H),0.93(d,J=24.6Hz,12H). 13 C NMR (101MHz, CDCl3) δ159.03,158.16,139.46,137.84,134.91,133.93,133.79,132.53,129.22,128.92,128.88,128.25, 127.76,127.06,119.93,119.90,116.30,115.26,83.11,77.37,77.05,76.74,55.14,54.88,39.59,24.88,24.75,20.91.11 B NMR(128MHz,CDCl3)δ33.21.HRMS(ESI)m / z:[M+Na] + calcd for C 31 H 37 BO4SiNa + :535.2446; found:535.2456.

[0250] Although the above embodiments have provided a detailed description of the present invention, they are only some embodiments of the present invention, and not all embodiments. People can obtain other embodiments based on these embodiments without creative effort, and these embodiments all fall within the protection scope of the present invention.

Claims

1. A method for preparing an α-boron-substituted cyclosilopentenene compound, characterized in that, Includes the following steps: Compound 1, compound 2, reducing agent and organic solvent were mixed and subjected to a [4+1] cycloaddition reaction to obtain α-boron-substituted cyclosilopentenene compounds; The structural formula of compound 1 is as follows: The structural formula of compound 2 is as follows: Wherein, R1 is a first aryl, aromatic heterocyclic or first alkyl; R2 is hydrogen or methyl; R3 is a second aryl or second alkyl; and R4 is a third aryl or third alkyl. When R1 is the first alkyl group or compound 1 is In this case, the system undergoing the cycloaddition reaction contains a catalyst.

2. The preparation method according to claim 1, characterized in that, The first aryl group includes 2-naphthyl, phenyl, or a first substituted phenyl group; the aromatic heterocycle includes benzodioxane, benzo4-membered ring, benzo5-membered ring, or furanyl; and the first alkyl group includes cyclohexyl, propyl, or n-octyl. The second aryl group includes phenyl or a second substituted phenyl group, and the second alkyl group includes methyl, n-propyl, isopropyl, or n-butyl. The third aryl group includes phenyl or a third substituted phenyl group, and the third alkyl group includes methyl, n-propyl, isopropyl, or n-butyl.

3. The preparation method according to claim 2, characterized in that, The substituents in the first substituted phenyl group include methyl, m-methyl, 3,4-dimethyl, ethyl, methoxy, ethoxy-o-methoxy, 3,4-dimethoxy, 3,4,5-trimethoxy, tert-butyl, phenyl, methylthio, N,N-dimethyl, benzylmethoxy, propoxy, fluorine, trimethylsilylalkynyl, etc. The substituents in the second substituted phenyl group include methyl, tert-butyl, n-butyl, or methoxy. The substituents in the third substituted phenyl group include methyl, tert-butyl, n-butyl, or methoxy.

4. The preparation method according to claim 1, characterized in that, The molar ratio of compound 1 to compound 2 is 1:1 to 3; The reducing agent includes magnesium powder, and the molar ratio of the reducing agent to compound 1 is 1 to 3:1; The organic solvent includes ethylene glycol dimethyl ether; The catalyst includes trichlorotitanium, and the molar ratio of the catalyst to compound 1 is 10-20:

100.

5. The preparation method according to any one of claims 1 to 4, characterized in that, The [4+1] cycloaddition reaction is carried out at a temperature of 40–80 °C for 20–24 h.

6. The preparation method according to claim 5, characterized in that, The [4+1] cycloaddition reaction is carried out under a protective atmosphere, which includes nitrogen or argon.

7. The preparation method according to claim 5, characterized in that, The [4+1] cycloaddition reaction further includes: separating and concentrating the system after the [4+1] cycloaddition reaction by column chromatography to obtain the α-boron-substituted cyclosilopentenene compound; The eluent used for column chromatography separation is a mixed solution of petroleum ether and ethyl acetate, wherein the volume ratio of petroleum ether to ethyl acetate is 20 to 100:

1.

8. The α-boron-substituted cyclosilopentenene compound prepared by the method according to any one of claims 1 to 7, characterized in that, It has any of the structural formulas shown in Equations 1 to 4: Wherein, R1 is a first aryl, aromatic heterocyclic or first alkyl; R2 is hydrogen or methyl; R3 is a second aryl or second alkyl; and R4 is a third aryl or third alkyl.

9. The α-boron-substituted cyclosilopentenene compound according to claim 8, characterized in that, It has any of the following structures:

10. The use of the α-boron-substituted cyclosilopentenene compounds of claim 8 or 9 in the fields of organic synthesis, medicinal chemistry, or materials science.